Clinical Trials on Methicillin-resistant Staphylococcus Aureus Septicemia in Italy
Total 6 results
-
PfizerCompletedSkin/Soft Tissue Infections | Methicillin Resistant Staphylococcus Aureus (MRSA)United States, Spain, United Kingdom, Colombia, Italy, Chile, Argentina, Mexico, Belgium, Russian Federation, Brazil, Malaysia, Singapore, Portugal, South Africa, Venezuela
-
Catholic University of the Sacred HeartUniversity Hospital, Geneva; Universiteit Antwerpen; Clinical Centre of Serbia; Canisius-Wilhelmina Hospital and other collaboratorsUnknownInfection Due to ESBL Bacteria | Bacterial Resistance | Infection Resistant to Multiple Drugs | Staph Aureus Methicillin Resistant ColonizationItaly, Romania, Serbia
-
ContraFectCompletedStaphylococcus Aureus Bacteremia | Staphylococcus Aureus EndocarditisUnited States, Belgium, Bulgaria, Chile, Czechia, France, Germany, Greece, Guatemala, Israel, Italy, Russian Federation, Spain, United Kingdom
-
Basilea PharmaceuticaDepartment of Health and Human ServicesCompletedStaphylococcus Aureus BacteremiaIsrael, United States, Georgia, Russian Federation, Ukraine, Colombia, Argentina, Bulgaria, Germany, Greece, Italy, Mexico, Panama, Serbia, South Africa, Spain, Turkey
-
UMC UtrechtMedImmune LLCCompletedStaphylococcus Aureus | Surgical Wound InfectionUnited Kingdom, Netherlands, Spain, Czechia, Serbia, Belgium, France, Estonia, Italy, Romania
-
University of ColognePfizerCompletedStaphylococcus Aureus | Wound Infection, Surgical | EpidemiologyGermany, Spain, France, Italy, United Kingdom